Impact of environmental endocrine disrupting chemicals on the development of obesity

Hormones

Volumn 9, Issue 3, 2010, Pages 206-217

  Newbold, Retha R ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Bisphenol A; Diabetes; Endocrine disruptors; Metabolic disease; Obesogens; Phthalates; Tributytin; Xenoestrogens

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; CARBAMIC ACID DERIVATIVE; CHLORPHENOTANE; DAIDZEIN; DIETHYLSTILBESTROL; ENDOCRINE DISRUPTOR; ENDRIN; GENISTEIN; HEAVY METAL; HEXACHLOROBENZENE; LINDANE; ORGANIC SOLVENT; ORGANOCHLORINE DERIVATIVE; ORGANOPHOSPHATE; ORGANOTIN COMPOUND; PESTICIDE; PHTHALIC ACID DERIVATIVE; PHYTOESTROGEN; POLYBROMINATED BIPHENYL; POLYCHLORINATED BIPHENYL DERIVATIVE; RESVERATROL; TETRABROMOBISPHENOL A; TRIBUTYLTIN; ZEARALENONE;

BODY WEIGHT; CARDIOVASCULAR DISEASE; DRUG MEGADOSE; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL IMPACT; EPIDEMIC; ESTROGEN ACTIVITY; HORMONAL REGULATION; HUMAN; LOW DRUG DOSE; METABOLIC SYNDROME X; NONHUMAN; OBESITY; REPRODUCTIVE TOXICITY; REVIEW; SIDE EFFECT; SIGNAL TRANSDUCTION; ANIMAL; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; PATHOPHYSIOLOGY; POLLUTANT; RISK ASSESSMENT; RISK FACTOR; WEIGHT GAIN;

ANIMALS; ENDOCRINE DISRUPTORS; ENVIRONMENTAL POLLUTANTS; HUMANS; OBESITY; RISK ASSESSMENT; RISK FACTORS; WEIGHT GAIN;

EID: 77956297058     PISSN: 11093099     EISSN: None     Source Type: Journal    
DOI: 10.14310/horm.2002.1271     Document Type: Review

References (93)

1. Ogden CL, Y anovski SZ, Carroll MD, Flegal KM, 2007 The epidemiology of obesity. Gastroenterology 132: 2087-2102.
2. Oken E, Gillman MW, 2003 Fetal origins of obesity. Obes Res 11: 496-506.
3. Cunningham E, 2010 Where can I find obesity statistics? J Am Diet Assoc 110: 656.
4. Caballero B, 2007 The global epidemic of obesity: an overview. Epidemiol Rev 29: 1-5.
5. CDC. Report on overweight and obesity, 2008 http://www.cdc.gov/nccdphp/dnpa/obesity. In: Centers for Disease Control and Prevention
6. McAllister E J, Dhurandhar N V, Keith SW, et al, 2009 Ten putative contributors to the obesity epidemic. Crit Rev Food Sci Nutr 49: 868-913.
7. Ogden CL, Flegal KM, Carroll MD, Johnson CL, 2002 Prevalence and trends in overweight among US children and adolescents, 1999-2000. JAMA 288: 1728-1732.
8. Flegal KM, Carroll MD, Ogden CL, Curtin LR, 2010 Prevalence and trends in obesity among US adults, 1999-2008. JAMA 303: 235-241.
9. Collins S, 2005 Overview of clinical perspectives and mechanisms of obesity. Birth Defects Res A Clin Mol Teratol 73: 470-471.
10. Mokdad A H, Ford E S, Bowman BA, et al, 2003 Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. JAMA 289: 76-79.
11. Mokdad A H, Serdula MK, Dietz WH, Bowman BA, Marks JS, Koplan JP, 1999 The spread of the obesity epidemic in the United States, 1991-1998. JAMA 282: 1519-1522.
12. Goncharov A, Haase R F, Santiago-Rivera A, et al, 2008 High serum PCBs are associated with elevation of serum lipids and cardiovascular disease in a N ative A merican population. Environ Res 106: 226-239.
13. Gladen BC, Ragan N B, Rogan WJ, 2000 Pubertal growth and development and prenatal and lactational exposure to polychlorinated biphenyls and dichlorodiphenyl dichloroethene. J Pediatr 136: 490-496.
14. Vasiliu O, Cameron L, Gardiner J, Deguire P, Karmaus W, 2006 Polybrominated biphenyls, polychlorinated biphenyls, body weight, and incidence of adult-onset diabetes mellitus. Epidemiology 17: 352-359.
15. Lee DH, L ee IK, Jin SH, Steffes M, Jacobs DR, Jr, 2007 Association between serum concentrations of persistent organic pollutants and insulin resistance among nondiabetic adults: results from the National Health and Nutrition Examination Survey 1999-2002. Diabetes Care 30: 622-628.
16. Lee DH, Steffes MW, Jacobs DR, Jr, 2008 Can persistent organic pollutants explain the association between serum gamma-glutamyltransferase and type 2 diabetes? Diabetologia 51: 402-407.
17. Pelletier C, Doucet E, Imbeault P, Tremblay A, 2002 Associations between weight loss-induced changes in plasma organochlorine concentrations, serum T(3) concentration, and resting metabolic rate. Toxicol Sci 67: 46-51.
18. Smink A, Ribas-Fito N, Garcia R, et al, 2008 Exposure to hexachlorobenzene during pregnancy increases the risk of overweight in children aged 6 years. Acta Paediatr 97: 1465-1469.
19. Stahlhut R W, van Wijngaarden E, Dye TD, Cook S, Swan SH, 2007 Concentrations of urinary phthalate metabolites are associated with increased waist circumference and insulin resistance in adult U.S. males. Environ Health Perspect 115: 876-882.
20. Hatch EE, N elson JW, Qureshi MM, et al, 2008 Association of urinary phthalate metabolite concentrations with body mass index and waist circumference: a cross-sectional study of N HANES data, 1999-2002. Environ Health 7: 27.
21. Takeuchi T, Tsutsumi O, Ikezuki Y, Takai Y, Taketani Y, 2004 Positive relationship between androgen and the endocrine disruptor, bisphenol A, in normal women and women with ovarian dysfunction. Endocr J 51: 165-169.
22. Coronado-Gonzalez JA, Del Razo L M, Garcia-Vargas G, Sanmiguel-Salazar F, Escobedo-de la Pena J, 2007 Inorganic arsenic exposure and type 2 diabetes mellitus in Mexico. Environ Res 104: 383-389.
23. Navas-Acien A, Silbergeld E K, Pastor-Barriuso R, Guallar E, 2008 A rsenic exposure and prevalence of type 2 diabetes in US adults. JAMA 300: 814-822.
24. Bern B, 1992 The Fragile Fetus. Princeton, NJ: Princeton Scientific Publishing Co.
25. Heindel JJ, 2007 Role of exposure to environmental chemicals in the developmental basis of disease and dysfunction. Reprod Toxicol 23: 257-259.
26. Heindel JJ, 2008 Animal models for probing the developmental basis of disease and dysfunction paradigm. Basic Clin Pharmacol Toxicol 102: 76-81.
27. Heindel JJ, Levin E, 2005 Developmental origins and environmental influences--Introduction. NIEHS symposium. Birth Defects Res A Clin Mol Teratol 73: 469.
28. Gluckman PD, Hanson MA, 2004 The developmental origins of the metabolic syndrome. Trends Endocrinol Metab 15: 183-187.
29. Colborn T, Dumanoski D, Myers JP, 1996. In Our Stolen Future. Penguin Books USA, Inc.
30. NIH, 1999 DES Research Update, NIH Publication N o. 00-4722, Bethesda, MD.
31. Barker DJ, E riksson JG, Forsen T, Osmond C, 2002 Fetal origins of adult disease: strength of effects and biological basis. Int J Epidemiol 31: 1235-1239.
32. vom Saal FS, Akingbemi BT, Belcher SM, et al, 2007 Chapel Hill bisphenol A expert panel consensus statement: integration of mechanisms, effects in animals and potential to impact human health at current levels of exposure. Reprod Toxicol 24: 131-138.
33. Anway MD, Cupp A S, Uzumcu M, Skinner MK, 2005 Epigenetic transgenerational actions of endocrine disruptors and male fertility. Science 308: 1466-1469.
34. Anway MD, Skinner MK, 2008 Epigenetic programming of the germ line: effects of endocrine disruptors on the development of transgenerational disease. Reprod Biomed Online 16: 23-25.
35. Newbold RR, Padilla-Banks E, Jefferson WN, 2006 Adverse effects of the model environmental estrogen diethylstilbestrol are transmitted to subsequent generations. Endocrinology 147: S11-17.
36. Skinner MK, Anway MD, 2007 Epigenetic transgenerational actions of vinclozolin on the development of disease and cancer. Crit Rev Oncog 13: 75-82.
37. Skinner MK, Anway MD, Savenkova MI, Gore AC, Crews D, 2008 Transgenerational epigenetic programming of the brain transcriptome and anxiety behavior. PLoS One 3: e3745.
38. Tang WY, Newbold R, Mardilovich K, et al, 2008 Persistent hypomethylation in the promoter of nucleosomal binding protein 1 (Nsbp1) correlates with overexpression of N sbp1 in mouse uteri neonatally exposed to diethylstilbestrol or genistein. Endocrinology 149: 5922-5931.
39. Baillie-Hamilton PF, 2002 Chemical toxins: a hypothesis to explain the global obesity epidemic. J Altern Complement Med 8: 185-192.
40. Heindel JJ, 2003 Endocrine disruptors and the obesity epidemic. Toxicol Sci 76: 247-249.
41. Newbold RR, Padilla-Banks E, Jefferson WN, Heindel JJ, 2008 Effects of endocrine disruptors on obesity. Int J Androl 31: 201-208.
42. Newbold RR, Padilla-Banks E, Snyder R J, Jefferson WN, 2005 Developmental exposure to estrogenic compounds and obesity. Birth Defects Res A Clin Mol Teratol 73: 478-480.
43. Newbold RR, Padilla-Banks E, Snyder R J, Jefferson WN, 2007 Perinatal exposure to environmental estrogens and the development of obesity. Mol Nutr Food Res 51: 912-917.
44. Newbold RR, Padilla-Banks E, Snyder R J, Phillips TM, Jefferson WN, 2007 Developmental exposure to endocrine disruptors and the obesity epidemic. Reprod Toxicol 23: 290-296.
45. Grun F, Blumberg B, 2006 Environmental obesogens: organotins and endocrine disruption via nuclear receptor signaling. Endocrinology 147: S50-55.
46. Grun F, Watanabe H, Zamanian Z, et al, 2006 Endocrinedisrupting organotin compounds are potent inducers of adipogenesis in vertebrates. Mol Endocrinol 20: 2141-2155.
47. Raun A, Preston R. History of diethylstilbestrol use in livestock. http://www.asas.org/oldsite/Bios/Raunhist.pdf 2002.
48. Newbold RR, 1995 Cellular and molecular effects of developmental exposure to diethylstilbestrol: implications for other environmnetal estrogens. Environmental Health Perspectives 103: 83-87.
49. McLachlan JA, Newbold RR, Bullock BC, 1980 Longterm effects on the female mouse genital tract associated with prenatal exposure to diethylstilbestrol. Cancer Research 40: 3988-3999.
50. Newbold RR, Bullock BC, McLachlan JA, 1990 Uterine adenocarcinoma in mice following developmental treatment with estrogens: a model for hormonal carcinogenesis. Cancer Research 50: 7677-7681.
51. Newbold R, 2004 Lessons Learned from Perinatal Exposure to Diethylstilbestrol (DES). Toxicology and Applied Pharmacology 199: 142-150.
52. Newbold RR, McLachlan JA, 1996 Transplacental hormonal carcinogenesis: diethylstilbestrol as an example. In: Huff J, Boyd J, Barrett JC(eds.), Cellular and Molecular Mechanisms of Hormonal Carcinogenesis: Environmental Influences. New York: Wiley-Liss; pp 131-147.
53. Gluckman PD, Hanson MA, Pinal C, 2005 The developmental origins of adult disease. Matern Child Nutr 1: 130-141.
54. Gillum R F, 1987 The association of the ratio of waist to hip girth with blood pressure, serum cholesterol and serum uric acid in children and youths aged 6-17 years. J Chronic Dis 40: 413-420.
55. Gesta S, Bluher M, Yamamoto Y, et al, 2006 Evidence for a role of developmental genes in the origin of obesity and body fat distribution. Proc Natl Acad Sci U S A 103: 6676-6681.
56. Newbold RR, Jefferson WN, Grissom SF, Padilla-Banks E, Snyder R J, Lobenhofer E K, 2007 Developmental exposure to diethylstilbestrol alters uterine gene expression that may be associated with uterine neoplasia later in life. Mol Carcinog 46: 783-796.
57. Nikaido Y, Yoshizawa K, Danbara N, et al, 2004 Effects of maternal xenoestrogen exposure on development of the reproductive tract and mammary gland in female CD-1 mouse offspring. Reprod Toxicol 18: 803-811.
58. Zoeller R T, Bansal R, Parris C, 2005 Bisphenol-A, an environmental contaminant that acts as a thyroid hormone receptor antagonist in vitro, increases serum thyroxine, and alters RC 3/neurogranin expression in the developing rat brain. Endocrinology 146: 607-612.
59. Brotons JA, O lea-Serrano MF, Villalobos M, O lea N, 1994 Xenoestrogens released from lacquer coating in food cans. Environmental Health Perspectives 103: 608-612.
60. Biles JE, McNeal TP, Begley TH, Hollifield HC, 1997 Determination of bisphenol-A in reusable polycarbonate food-contact plastics and migration to food simulating liquids. Journal Agric Food Chem 45: 3541-3544.
61. Olea N, Pulgar R, Perez P, et al, 1996, Estrogenicity of resin-based composites and sealants used in dentistry. Environ Health Perspect 104: 298-305.
62. Calafat AM, Ye X, Wong LY, Reidy JA, Needham LL, 2008 Exposure of the U.S. population to bisphenol A and 4-tertiary-octylphenol: 2003-2004. Environ Health Perspect 116: 39-44.
63. Takeuchi T, Tsutsumi O, 2002 Serum bisphenol a concentrations showed gender differences, possibly linked to androgen levels. Biochem Biophys Res Commun 291: 76-78.
64. Ye X, Kuklenyik Z, Needham LL, Calafat A M, 2006 Measuring environmental phenols and chlorinated organic chemicals in breast milk using automated on-line column-switching-high performance liquid chromatography- isotope dilution tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 831: 110-115.
65. Padmanabhan V, Siefert K, Ransom S, et al, 2008 Maternal bisphenol-A levels at delivery: a looming problem? J Perinatol 28: 258-263.
66. Schonfelder G, Flick B, Mayr E, Talsness C, Paul M, Chahoud I, 2002 In utero exposure to low doses of bisphenol A lead to long-term deleterious effects in the vagina. Neoplasia 4: 98-102.
67. Tetrabromobisphenol A and derivatives: E nvironmental Health Criteria no. 172. In. Geneva: World Health Organization; 1995.
68. European Union Updated European Risk Assessment Report 4,4'-Isopropylidenediphenol (Bisphenol A). Environment Addendum of February 2008 (to be read in conjunction withEU RAR of BPA published in 2003). http:ecb.jrc.it/documents/Existing-Chemicals/RISKASSESSMENT/ADDENDUM/bisphenolaadd325.pdf). In; 2008.
69. Thomsen C, Thomsen C, Lundanes E, Becher G, 2002 Brominated flame retardants in archived serum samples from Norway: a study on temporal trends and the role of age. Environ Sci Technol 36: 1414-1418.
70. Wetherill Y B, Akingbemi BT, Kanno J, et al, 2007 In vitro molecular mechanisms of bisphenol A action. Reprod Toxicol 24: 178-198.
71. NTP. CEHR Brief on Bisphenol A. National Toxicology Program, Research Triangle Park, NC. 2008.
72. Richter CA, Birnbaum LS, Farabollini F, et al, 2007 In vivo effects of bisphenol A in laboratory rodent studies. Reprod Toxicol 24: 199-224.
73. Howdeshell KL, Hotchkiss AK, Thayer KA, Vandenbergh JG, vom Saal FS, 1999 Exposure to bisphenol A advances puberty. Nature 401: 763-764.
74. Ashby J, Tinwell H, Haseman J, 1999 Lack of effects for low dose levels of bisphenol A and diethylstilbestrol on the prostate gland of C F1 mice exposed in utero. Regul Toxicol Pharmacol 30: 156-166.
75. Takai Y, Tsutsumi O, Ikezuki Y, et al, 2001 Preimplantation exposure to bisphenol A advances postnatal development. Reprod Toxicol 15: 71-74.
76. Honma S, Suzuki A Buchanan DL, Katsu Y, Watanabe H, Iguchi T, 2002 Low dose effect of in utero exposure to bisphenol A and diethylstilbestrol on female mouse reproduction. Reprod Toxicol 16: 117-122.
77. Nikaido Y, Danbara N, Tsujita-Kyutoku M, Yuri T, Uehara N, Tsubura A, 2005 Effects of prepubertal exposure to xenoestrogen on development of estrogen target organs in female CD-1 mice. In Vivo 19: 487-494.
78. Rubin BS, Murray MK, Damassa DA, King JC, Soto AM, 2001 Perinatal exposure to low doses of bisphenol A affects body weight, patterns of estrous cyclicity, and plasma L H levels. Environ Health Perspect 109: 675-680.
79. Somm E, Schwitzgebel VM, Toulotte A, et al 2009 Perinatal exposure to bisphenol a alters early adipogenesis in the rat. Environ Health Perspect 117: 1549-1555.
80. Sakurai K, Kawazuma M, Adachi T, et al, 2004 Bisphenol A affects glucose transport in mouse 3T3-F442A adipocytes. Br J Pharmacol 141: 209-214.
81. Masuno H, Kidani T, Sekiya K, et al, 2002 Bisphenol A in combination with insulin can accelerate the conversion of 3T3-L1 fibroblasts to adipocytes. J Lipid Res 43: 676-684.
82. Masuno H, Iwanami J, Kidani T, Sakayama K, Honda K, 2005 Bisphenol a accelerates terminal differentiation of 3T3-L1 cells into adipocytes through the phosphatidylinositol 3-kinase pathway. Toxicol Sci 84: 319-327.
83. Alonso-Magdalena P, Laribi O, Ropero A B, et al, 2005 Low doses of bisphenol A and diethylstilbestrol impair Ca2+ signals in pancreatic alpha-cells through a nonclassical membrane estrogen receptor within intact islets of Langerhans. Environ Health Perspect 113: 969-977.
84. Alonso-Magdalena P, Morimoto S, Ripoll C Fuentes E, Nadal A, 2006 The estrogenic effect of bisphenol A disrupts pancreatic beta-cell function in vivo and induces insulin resistance. Environ Health Perspect 114: 106-112.
85. Ben-Jonathan N, Hugo ER, Brandebourg TD 2009 Effects of bisphenol A on adipokine release from human adipose tissue: Implications for the metabolic syndrome. Mol Cell Endocrinol 304: 49-54.
86. Hugo ER, Brandebourg TD, Woo JG, L oftus J, Alexander JW, Ben-Jonathan N, 2008 Bisphenol A at environmentally relevant doses inhibits adiponectin release from human adipose tissue explants and adipocytes. Environ Health Perspect 116: 1642-1647.
87. Ropero A B, Alonso-Magdalena P, Garcia-Garcia E, Ripoll C, Fuentes E, Nadal A, 2008 Bisphenol-A disruption of the endocrine pancreas and blood glucose homeostasis. Int J Androl 31: 194-200.
88. Moutsatsou P, 2007 The spectrum of phytoestrogens in nature: our knowledge is expanding. Hormones (Athens) 6: 173-193.
89. Penza M, Montani C, Romani A, et al, 2006 Genistein affects adipose tissue deposition in a dose-dependent and gender-specific manner. Endocrinology 147: 5740-5751.
90. Tabb MM, Blumberg B, 2006 New modes of action for endocrine-disrupting chemicals. Mol Endocrinol 20: 475-482.
91. Melzer D, Rice N, Depledge MH, Henley WE, Galloway TS, 2010 Association between serum perfluoroctanoic acid (PFOA) and Thyroid Disease in the U.S. National Health and Nutrition Examination Survey. Environ Health Perspect 118: 686-692.
92. Shinomiya N, Shinomiya M, 2003 Dichlorodiphenyltrichloroethane suppresses neurite outgrowth and induces apoptosis in PC12 pheochromocytoma cells. Toxicol Lett 137: 175-183.
93. Stettler N, Stallings VA, Troxel A B, et al, 2005 Weight gain in the first week of life and overweight in adulthood: a cohort study of European American subjects fed infant formula. Circulation 111: 1897-1903.